BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22782629)

  • 1. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.
    Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V
    Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.
    Hamai Y; Matsumura S; Matsusaki K; Kitadai Y; Yoshida K; Yamaguchi Y; Imai K; Nakachi K; Toge T; Yasui W
    Pathobiology; 2005; 72(3):133-8. PubMed ID: 15860930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between functional EGF+61 polymorphism and glioma risk.
    Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
    Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population.
    Lim YJ; Kim JW; Song JY; Hong MS; Jin SY; Yoon SH; Park HJ; Choe BK; Lee JJ; Yim SV; Hong SI; Baik HH; Ha E; Park YH
    Neurosci Lett; 2005 Feb; 374(3):157-60. PubMed ID: 15663953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
    Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
    Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
    DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population.
    Li Y; Zhao Y; Liu J; Liu P; Xu Y
    Genet Test Mol Biomarkers; 2012 May; 16(5):449-52. PubMed ID: 22106858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
    Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
    Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between EGF +61 A/G polymorphism and increased risk of glioma.
    Liu X; Li L; Chen X; Wang X; Mu L; Li Y; Xu Q; Xie Q; Lu F
    Int J Biol Markers; 2009; 24(2):77-82. PubMed ID: 19634110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma.
    Vauleon E; Auger N; Benouaich-Amiel A; Laigle-Donadey F; Kaloshi G; Lejeune J; Delattre JY; Thillet J; Sanson M
    Cancer Genet Cytogenet; 2007 Jan; 172(1):33-7. PubMed ID: 17175377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.
    Trizna Z; de Andrade M; Kyritsis AP; Briggs K; Levin VA; Bruner JM; Wei Q; Bondy ML
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):553-5. PubMed ID: 9641501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of rapid acetylator genotypes in patients with brain astrocytoma and meningioma.
    Olivera M; Martínez C; Molina JA; Alonso-Navarro H; Jiménez-Jiménez FJ; García-Martín E; Benítez J; Agúndez JA
    Acta Neurol Scand; 2006 May; 113(5):322-6. PubMed ID: 16629768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival.
    Almeida LO; Custódio AC; Santos MJ; Almeida JR; Clara CA; Pinto GR; Rey JA; Casartelli C
    Cancer Genet Cytogenet; 2010 Apr; 198(1):15-21. PubMed ID: 20303009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.